 |
Sanofi-aventis' new insulin injection more efficientSanofi-aventis has announced the results of new analysis that found a significantly lower risk of nocturnal hypoglycemia with Lantus (insulin glargine [rDNA] injection) as compared to NPH insulin. A separate post-hoc sub-analysis found a g More… |
Wednesday 25 December 2024
